UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052363
Receipt number R000059779
Scientific Title Establishment of methods for inducing visual and vibrational sense in resonance frequency breathing
Date of disclosure of the study information 2023/10/01
Last modified on 2023/10/01 10:40:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of methods for inducing visual and vibrational sense in resonance frequency breathing

Acronym

Induction of resonance frequency breathing

Scientific Title

Establishment of methods for inducing visual and vibrational sense in resonance frequency breathing

Scientific Title:Acronym

Induction of resonance frequency breathing

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Psychosomatic Internal Medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of inducing visual and vibrational sense in resonance frequency breathing

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Percentage of time determined to be at resonant frequency during resonance frequency breathing

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

With visual guidance

Interventions/Control_2

With vibratory guidance

Interventions/Control_3

Without guidance

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy volunteer

Key exclusion criteria

1) Those who are currently on medication or outpatient treatment
2) Those with mental disorders that makes communication difficult

Target sample size

72


Research contact person

Name of lead principal investigator

1st name Hideaki
Middle name
Last name Hasuo

Organization

Kansai Medical University

Division name

Department of Psychosomatic Medicine

Zip code

573-1010

Address

Shinmachi 2-5-1-505, Hirakata, Osaka

TEL

0728040101

Email

hasuohid@hirakata.kmu.ac.jp


Public contact

Name of contact person

1st name Hideaki
Middle name
Last name Hasuo

Organization

Department of Psychosomatic Medicine

Division name

Department of Psychosomatic Medicine

Zip code

573-1010

Address

Shinmachi 2-5-1-505, Hirakata, Osaka

TEL

0728040101

Homepage URL


Email

hasuohid@hirakata.kmu.ac.jp


Sponsor or person

Institute

Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University

Address

Shinmachi 2-5-1-505, Hirakata, Osaka

Tel

0728040101

Email

hasuohid@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2023 Year 12 Month 01 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 01 Day

Last modified on

2023 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059779